Everything I read about Essa Pharma (NASDAQ: EPIX) sounds positive. They claim to have a game-changing prostate cancer technology and significant news ahead. But it is very difficult to buys shares because the 1M float seems tightly held. Four institutions (BVF, Clarus, Omega, Eventide) own 90% of common paid well over $12 for their shares, an analyst has a $24/share price target, and it's funded to 2020. Please help me understand its technical setup because fundamentals seem strong but I don't know much about technical analysis. Thank you!
Note
I found this recent article on the EPIX Stocktwits message board and everything checks based on my independent due diligence. seekingalpha.com/instablog/49172045-mikeyknows2020/5261084-epix-update-2-new-information-suggests-upside-significantly-higher-previously-thoughtNote
Keep an eye on EPIX starting next week....you might fall in love with it too seekingalpha.com/instablog/49172045-mikeyknows2020/5265849-update-3-investors-will-fall-love-epix-valentines-day
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.